Intrinsiqs

Is Bristol-Myers Squibb Company overvalued?

Bristol-Myers Squibb Company (BMY) looks undervalued — trading about 12% below its fair value.

Undervalued
Current price $62.86 Fair value $70.12
Price
$62.86
Fair value
$70.12
Current P/E
18.2
Normal P/E
20.3
Market cap
$128.40B
Dividend yield
4.1%
Return on equity
46.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BMY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated